[go: up one dir, main page]

HUP9802741A2 - Tiagabin-hidrokloridot tartalmazó gyógyszerkészítmény és eljárás annak előállítására - Google Patents

Tiagabin-hidrokloridot tartalmazó gyógyszerkészítmény és eljárás annak előállítására

Info

Publication number
HUP9802741A2
HUP9802741A2 HUP9802741A HUP9802741A2 HU P9802741 A2 HUP9802741 A2 HU P9802741A2 HU P9802741 A HUP9802741 A HU P9802741A HU P9802741 A2 HUP9802741 A2 HU P9802741A2
Authority
HU
Hungary
Prior art keywords
preparation
medicinally
pharmaceutical composition
composition containing
tiagabine hydrochloride
Prior art date
Application number
Other languages
English (en)
Inventor
Tina Meinertz Andersen
Thyge Borup Hjorth
Lars Nygaard
Jorgen Svensson
Helle Weibel
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of HUP9802741A2 publication Critical patent/HUP9802741A2/hu
Publication of HUP9802741A3 publication Critical patent/HUP9802741A3/hu
Publication of HU223075B1 publication Critical patent/HU223075B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

A találmány tárgya gyógyszerkészítmény, azzal jellemezve, hőgy (a) tiagabint vagy annak valamely gyógyászatilag elfőgadható sóját, (b) tiagabint vagy annak gyógyászatilag elfőgadható sóját kielégítőmennyiségben stabilizáló egy vagy több gyógyászatilag elfőgadhatóantiőxidánst, és (c) kívánt esetben valamely gyógyászatilag elfőgadható vívőanyagőttartalmaz. A találmány tárgya tővábbá eljárás a fenti gyógyszerkészítményelőállítására. A találmány szerinti gyógyszerkészítmény stabil és antiepileptikűsaktivitással rendelkezik. ŕ
HU9802741A 1995-05-05 1996-04-29 Tiagabint, illetve sóját tartalmazó gyógyszerkészítmény és eljárás annak előállítására HU223075B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK52395 1995-05-05
PCT/DK1996/000192 WO1996034606A1 (en) 1995-05-05 1996-04-29 Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation

Publications (3)

Publication Number Publication Date
HUP9802741A2 true HUP9802741A2 (hu) 1999-03-29
HUP9802741A3 HUP9802741A3 (en) 1999-04-28
HU223075B1 HU223075B1 (hu) 2004-03-01

Family

ID=8094516

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802741A HU223075B1 (hu) 1995-05-05 1996-04-29 Tiagabint, illetve sóját tartalmazó gyógyszerkészítmény és eljárás annak előállítására

Country Status (26)

Country Link
US (1) US5866590A (hu)
EP (1) EP0830132B1 (hu)
JP (1) JP3195360B2 (hu)
KR (1) KR100440354B1 (hu)
CN (1) CN1092959C (hu)
AR (1) AR003418A1 (hu)
AT (1) ATE211911T1 (hu)
AU (1) AU707508B2 (hu)
BR (1) BR9608120A (hu)
CA (1) CA2220019C (hu)
CZ (1) CZ292256B6 (hu)
DE (1) DE69618586T2 (hu)
DK (1) DK0830132T3 (hu)
EG (1) EG23781A (hu)
ES (1) ES2171669T3 (hu)
HU (1) HU223075B1 (hu)
IL (1) IL118142A (hu)
MX (1) MX9708394A (hu)
MY (1) MY115016A (hu)
NO (1) NO318599B1 (hu)
NZ (1) NZ307159A (hu)
PL (1) PL183678B1 (hu)
PT (1) PT830132E (hu)
UA (1) UA43402C2 (hu)
WO (1) WO1996034606A1 (hu)
ZA (1) ZA963478B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
ES2172179T3 (es) * 1997-08-01 2002-09-16 Elan Corp Plc Composiciones farmaceuticas de liberacion controlada que contienen tiagabina.
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
EP1017386A1 (en) * 1997-10-02 2000-07-12 H. Lundbeck A/S GRANULAR PREPARATIONS OF 5-(2-ETHYL- 2$i(H)-TETRAZOL- 5-YL)-1-METHYL-1, 2,3,6-TETRAHYDROPYRIDINE
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
ZA99407B (en) * 1998-01-22 1999-07-20 Abbott Lab Extended release tiagabine formulations with reduced side-effects.
AU2002325404B2 (en) * 1998-01-22 2006-02-02 Abbott Laboratories Extended Release Tiagabine Formulations with Reduced Side-effects
EP1303273A1 (en) * 2000-05-26 2003-04-23 Novo Nordisk A/S New pharmaceutical composition and the process for its preparation
AU2000249111A1 (en) * 2000-05-30 2001-12-11 Dr. Reddy's Research Foundation New pharmaceutical composition and the process for its preparation
WO2006067605A1 (en) * 2004-12-23 2006-06-29 Ranbaxy Laboratories Limited Stable pharmaceutical compositions of tiagabine and processes for their preparation
CN102125693A (zh) * 2011-01-25 2011-07-20 福建科瑞药业有限公司 一种盐酸噻加宾药物组合物及其制备方法
CA2873016A1 (en) * 2012-05-08 2013-11-14 Cellixbio Private Limited Compositions and methods for the treatment of epilepsy
US20190015513A1 (en) * 2015-08-28 2019-01-17 Nippon Kayaku Kabushiki Kaisha Pharmaceutical composition comprising rapamycin or derivative thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US501090A (en) * 1893-07-11 gennert
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
FR2698788B1 (fr) 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies

Also Published As

Publication number Publication date
ZA963478B (en) 1996-11-13
CA2220019A1 (en) 1996-11-07
EG23781A (en) 2007-08-13
ES2171669T3 (es) 2002-09-16
AU707508B2 (en) 1999-07-15
CA2220019C (en) 2007-12-11
PL323138A1 (en) 1998-03-16
JPH10505359A (ja) 1998-05-26
HUP9802741A3 (en) 1999-04-28
EP0830132A1 (en) 1998-03-25
DE69618586T2 (de) 2002-09-05
JP3195360B2 (ja) 2001-08-06
WO1996034606A1 (en) 1996-11-07
NO318599B1 (no) 2005-04-18
PL183678B1 (pl) 2002-06-28
MX9708394A (es) 1998-02-28
US5866590A (en) 1999-02-02
UA43402C2 (uk) 2001-12-17
KR100440354B1 (ko) 2004-09-18
DK0830132T3 (da) 2002-04-29
ATE211911T1 (de) 2002-02-15
CN1183721A (zh) 1998-06-03
DE69618586D1 (de) 2002-02-21
HU223075B1 (hu) 2004-03-01
CN1092959C (zh) 2002-10-23
NZ307159A (en) 1998-10-28
CZ292256B6 (cs) 2003-08-13
NO975076L (no) 1997-11-04
AU5644196A (en) 1996-11-21
AR003418A1 (es) 1998-08-05
BR9608120A (pt) 1999-02-09
EP0830132B1 (en) 2002-01-16
NO975076D0 (no) 1997-11-04
MY115016A (en) 2003-03-31
PT830132E (pt) 2002-07-31
IL118142A (en) 1999-11-30
CZ338897A3 (cs) 1998-03-18
IL118142A0 (en) 1996-09-12

Similar Documents

Publication Publication Date Title
TW221811B (hu)
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
EE03253B1 (et) (R)-5-karbamoüül-8-fluoro-3-N,N-diasendatud-amino-3,4-dihüdro-2H-1-bensopüraani d, nende valmistamise protsess ja neid sisaldavad ravimkoostised
HUP9901079A3 (en) 5- and 6-membered cyclic compounds containing nitrogenatom, pharmaceutical compositions containing them, their use for producing pharmaceutical compositions and their producing
HUP9802741A2 (hu) Tiagabin-hidrokloridot tartalmazó gyógyszerkészítmény és eljárás annak előállítására
HUT37424A (en) Process for preparing new 5-pyridyl-1,3-thiazoie derivatives and pharmaceutical compositions containing thereof as active substances
MY114388A (en) Multiple unit pharmaceutical preparation
HUT49358A (en) Process for producing phosphorous compounds, pharmaceutical compositions comprising same as active ingredient and intermediaries
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
IL82448A0 (en) Tetrahydronaphthalene derivatives,their manufacture and pharmaceutical compositions containing them
HUT70851A (en) Organic salts of n,n`-diacetyl-cystine, pharmaceutical compositions containing them and process for preparing them
IL117091A0 (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
BG105161A (en) Benzocycloheptenes, methods for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
AU2705588A (en) New ciclosporin crystal form, processes for its production, pharmaceutical compositions containing it and its use.
IL55429A0 (en) Thiadiaolyl cephalosporin analogs, processes for the preparation thereof,pharmaceutical or veterinary compositions containing the same and method of inhibiting the growth of bacteria therewith
EP0460062A4 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
ATE215817T1 (de) Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
HUP0001780A2 (hu) Stabilizált tibolont tartalmazó készítmények és eljárás előállításukra
HUT41750A (en) Process for preparing 2-hydroxy-4h-3,1-benzazin-4-one derivatives, pharmaceutical compositions containing thereof as active ingredients and intermediers thereof
HUT56556A (en) Process for producing new piperazinecarboxamides containing phenoxyalkyl or thiophenoxyalkyl side chain, as well as pharmaceutical compositions comprising such compounds as active ingredient
IL112999A0 (en) Crystalline salts of 2,3,4,5- tetrahydro -1h-3-benzazepine compounds, their preparation and pharmaceutical compositions containing them
HUT63151A (en) Process for producing new benzimidazole-2-sulfonamide and imidazopyuridine-2-sylfonamide derivatives, as well as pharmaceutical compositions comprising same as active ingredient
IL89666A0 (en) Compounds for inhibiting the biosynthesis of lipoxygenase-derived metabolites of arachidonic acid,their production and pharmaceutical compositions containing them
IL81546A (en) N-(alpha-(4-diphenylalkyl-piperazin-1-ylmethyl))-purine-ethanol derivatives,their production and pharmaceutical compositions containing them
EP1059304A4 (en) NOVEL POLYSACCHARIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITIONS CONTAINING THESE NEW DERIVATIVES AS ACTIVE INGREDIENT

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20040114

MM4A Lapse of definitive patent protection due to non-payment of fees